P3 Health Partners Inc
NASDAQ:PIII
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P3 Health Partners Inc
NASDAQ:PIII
|
US |
|
Merit Group PLC
LSE:MRIT
|
UK |
|
Shree Renuka Sugars Ltd
NSE:RENUKA
|
IN |
|
O
|
Orcay Ortakoy Cay Sanayi ve Ticaret AS
IST:ORCAY.E
|
TR |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
A
|
Allegiant Professional Business Services Inc
OTC:APRO
|
US |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
US |
|
Scansource Inc
NASDAQ:SCSC
|
US |
|
PubMatic Inc
NASDAQ:PUBM
|
US |
|
Selaras Citra Nusantara Perkasa Tbk PT
IDX:SCNP
|
ID |
|
Airtificial Intelligence Structures SA
F:IRG
|
ES |
|
Bank Negara Indonesia (Persero) Tbk PT
IDX:BBNI
|
ID |
|
TNG Ltd
ASX:TNG
|
AU |
Wall Street
Price Targets
PIII Price Targets Summary
P3 Health Partners Inc
According to Wall Street analysts, the average 1-year price target for
PIII
is 10.71 USD
with a low forecast of 8.08 USD and a high forecast of 13.13 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PIII's stock price target?
Price Target
10.71
USD
According to Wall Street analysts, the average 1-year price target for
PIII
is 10.71 USD
with a low forecast of 8.08 USD and a high forecast of 13.13 USD.
What is P3 Health Partners Inc's Revenue forecast?
Projected CAGR
6%
For the last 6 years the
compound annual growth rate for
P3 Health Partners Inc's revenue is
47%.
The projected
CAGR
for the next 2 years is
6%.
